NAFLD-related hepatocellular carcinoma: The growing challenge

被引:90
|
作者
Shah, Pir Ahmad [1 ]
Patil, Rashmee [2 ]
Harrison, Stephen A. [3 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Internal Med, San Antonio, TX 78229 USA
[2] South Texas Res Inst, Edinburg, TX USA
[3] Univ Oxford, Radcliffe Dept Med, Oxford, England
关键词
NONALCOHOLIC FATTY LIVER; ADIPONECTIN GENE POLYMORPHISMS; LONG-TERM OUTCOMES; RISK-FACTORS; UNITED-STATES; METABOLIC SYNDROME; JAPANESE PATIENTS; DISEASE NAFLD; PNPLA3; GENE; CANCER;
D O I
10.1002/hep.32542
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a common cause of cancer-related mortality and morbidity worldwide. With the obesity pandemic, NAFLD-related HCC is contributing to the burden of disease exponentially. Genetic predisposition and clinical risk factors for NAFLD-related HCC have been identified. Cirrhosis is a well-known and major risk factor for NAFLD-related HCC. However, the occurrence of NAFLD-related HCC in patients without cirrhosis is increasingly recognized and poses a significant challenge regarding cancer surveillance. It is of paramount importance to develop optimal risk stratification scores and models to identify subsets of the population at high risk so they can be enrolled in surveillance programs. In this review, we will discuss the risks and prediction models for NAFLD-related HCC.
引用
收藏
页码:323 / 338
页数:16
相关论文
共 50 条
  • [1] NAFLD-related hepatocellular carcinoma
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05): : 392 - 392
  • [2] Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
    Jeong, Seogsong
    Shin, Woo-Young
    Oh, Yun Hwan
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [3] NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden
    Georgescu, Doina
    Lighezan, Daniel Florin
    Rosca, Ciprian Ilie
    Nistor, Daciana
    Ancusa, Oana Elena
    Suceava, Ioana
    Iancu, Mihaela Adela
    Kundnani, Nilima Rajpal
    [J]. LIFE-BASEL, 2024, 14 (01):
  • [4] NAFLD-Related Hepatocellular Carcinoma and the Four Horsemen of the Apocalypse
    Debes, Jose D.
    Boonstra, Andre
    de Knegt, Robert J.
    [J]. HEPATOLOGY, 2020, 71 (03) : 774 - 776
  • [5] Clinical features and outcomes of NAFLD-related hepatocellular carcinoma
    Liu, Lei
    Liao, Rui
    [J]. LANCET ONCOLOGY, 2022, 23 (06): : E243 - E243
  • [6] Clinical features and outcomes of NAFLD-related hepatocellular carcinoma reply
    Tan, Darren Jun Hao
    Ng, Cheng Han
    Muthiah, Mark D.
    Loomba, Rohit
    Huang, Daniel Q.
    [J]. LANCET ONCOLOGY, 2022, 23 (06): : E244 - E244
  • [7] The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma
    Zhang, Chunye
    Yang, Ming
    [J]. CANCERS, 2021, 13 (15)
  • [8] Editorial: NAFLD-related hepatocellular carcinoma - increasing or not? With or without cirrhosis?
    Balakrishnan, M.
    El-Serag, H. B.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (03) : 437 - 438
  • [9] Pathogenesis of NAFLD-Related Hepatocellular Carcinoma: An Up-to-Date Review
    Gao, Yinghui
    Zhu, Ruirui
    Dong, Jianxia
    Li, Zhiqin
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 347 - 356
  • [10] NAFLD-related HCC
    Banini, Bubu A.
    Sanyal, Arun J.
    [J]. MECHANISMS AND THERAPY OF LIVER CANCER, 2021, 149 : 143 - 169